Polymorphisms in the hypoxia-inducible factor 1 alpha gene in Mexican patients with preeclampsia: A case-control study

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Nava Salazar, Sonia ^a   Snchez Rodríguez, Elly N ^a   Mendoza Rodríguez, C Adriana ^a   Moran, Carlos ^b   Romero Arauz, Juan F ^b   Cerbán, Marco A ^b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952698837     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-68     Document Type: Article

References (37)

1. Diagnosis and management of preeclampsia and eclampsia. Number 33. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin, Obstet Gynecol 2002 99 159 67 10.1016/S0029-7844(01)01747-1 16175681
2. Preeclampsia. B Sibai G Dekker M Kupferminc, Lancet 2005 365 785 97 15733721
3. Prevencián, diagnástico y manejo de la preeclampsia/ eclampsia. Secretaría de Salud. Lineamiento Técnico, México, DF 4 2007
4. Epidemiología, clasificacián y factores de riesgo en preeclampsia. JF Romero Arauz G Tena Alavez, Enfermedades hipertensivas del embarazo, McGrawHill, México, 2009 1 15
5. Mortalidad materna en el IMSS, 1991-2005. Un periodo de cambios. ME Velasco HE Navarrete, Rev Med Inst Mex Seguro Soc 2006 44 121 8 17410867
6. Maternal near miss and maternal death in the World Health Organization's 2005 global survey on maternal and perinatal health. JP Souza JG Cecatti A Faundes SS Morais J Villar G Carroli M Gulmezoglu D Wojdyla N Zavaleta A Donner A Velazco V Bataglia E Valladares M Kublickas A Acosta, Bull World Health Organ 2010 88 113 9 10.2471/BLT.08.057828 20428368
7. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? Y Zhou CH Damsky SJ Fisher, J Clin Invest 1997 99 2152 64 10.1172/JCI119388 9151787 (Pubitemid 27203771)
8. Preeclampsia and angiogenic imbalance. S Maynard FH Epstein SA Karumanchi, Annu Rev Med 2008 59 61 78 10.1146/annurev.med.59.110106.214058 17937587 (Pubitemid 351287924)
9. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. GL Semenza GL Wang, Mol Cell Biol 1992 12 5447 54 1448077
10. Expression, ontogeny, and regulation of hypoxia-inducible transcription factors in the human placenta. A Rajakumar K Conrad, Biol Reprod 2000 63 559 69 10.1095/biolreprod63.2.559 10906065 (Pubitemid 30639947)
11. Oxigen and placental development during the first trimester: Implications for the patophysiology of pre-eclampsia. I Caniggia J Winter S Lye M Post, Placenta 2000 21 Suppl A 25 30 10.1053/plac.1999.0522 10831118
12. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen - a review. A Ahmed C Dunk S Ahmad A Khaliq, Placenta 2000 21 Suppl A 16 24 10.1053/plac.1999.0524 10831117
13. Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways. T Snchez-Elsner LM Botella B Velasco C Langa C Bernabéu, J Biol Chem 2002 277 43799 808 12228247 (Pubitemid 36157800)
14. Selective overexpression of the hypoxia-inducible transcription factor, HIF-2a, in placentas from women with preeclampsia. A Rajakumar A Whitelock L Weissfeld A Daftary N Markovic, Biol Reprod 2001 64 499 506 11159352 (Pubitemid 32109738)
15. Hypoxia inducible factor-1: Oxygen regulation of trophoblast differentiation in normal and pre-eclamptic Pregnancies - A Review. I Caniggia JL Winter, Placenta 2002 16 Suppl A 47 57 10.1053/plac.2002.0815 (Pubitemid 39658613)
16. Circulating angiogenic factors and the risk of preeclampsia. RJ Levine SE Maynard C Qian KH Lim LJ England KF Yu EF Schisterman R Thadhani BP Sachs FH Epstein BM Sibai VP Sukhatme SA Karumanchi, N Engl J Med 2004 350 672 83 10.1056/NEJMoa031884 14764923 (Pubitemid 38364626)
17. Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia - a step forward but not the definitive answer. JM Foidart JP Schaaps F Chantraine C Munaut S Lorquet, J Reprod Immunol 2009 82 106 11 10.1016/j.jri.2009.09.001 19853925
18. Hypoxia-inducible factor-1a polymorphisms associated with enhanced transactivation capacity, implying clinical significance. K Tanimoto K Yoshiga H Eguchi M Kaneyasu K Ukon T Kumazaki N Oue W Yasui K Imai K Nakachi L Poellinger M Nishiyama, Carcinogenesis 2003 24 1779 83 10.1093/carcin/bgg132 12919954 (Pubitemid 37408141)
19. Genetic variation in the HIF-1 gene is associated with type 2 diabetes in Japanese. N Yamada Y Horikawa N Oda K Lizuka N Shihara S Kishi J Takeda, J Clin Endocrinol Metab 2005 90 5841 7 10.1210/jc.2005-0991 16046581 (Pubitemid 41415501)
20. Hypoxia-inducible factor-1 polymorphisms and TSC1/2 mutations are complementary in head and neck cancers. C Hebert K Norris P Parashar R Ord N Nikitakis J Sauk, Mol Cancer 2006 5 1 11 10.1186/1476-4598-5-3 16403226
21. The C1772T genetic polymorphism in human HIF-1alpha gene associates with expression of HIF-1alpha protein in breast cancer. HO Kim YH Jo J Lee SS Lee KS Yoon, Oncol Rep 2008 20 1181 7 18949419
22. Polymorphisms in hypoxia inducible factor 1 and the initial clinical presentation of coronary disease. MA Hlatky T Quertermous DB Boothroyd JR Priest AJ Glassford RM Myers SP Fortmann C Iribarren HK Tabor TL Assimes RJ Tibshirani AS Go, Am Heart J 2007 154 1035 42 10.1016/j.ahj.2007.07.042 18035072 (Pubitemid 350116043)
23. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma. SC Clifford D Astuti L Hooper PH Maxwell PJ Ratcliffe ER Maher, Oncogene 2001 20 5067 74 10.1038/sj.onc.1204602 11526493 (Pubitemid 32769798)
24. Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation. XS Fu E Choi GJ Bubley SP Balk, Prostate 2005 63 215 21 10.1002/pros.20190 15538748 (Pubitemid 40571055)
25. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. K Duckitt D Harrington, BMJ 2005 330 565 571 10.1136/bmj.38380.674340.E0 15743856
26. Pre-eclampsia. EA Steegers P von Dadelszen JJ Duvekot R Pijnenborg, Lancet 2010 376 631 44 10.1016/S0140-6736(10)60279-6 20598363
27. Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. A Conde-Agudelo F Althabe JM Belizn AC Kafury-Goeta, Am J Obstet Gynecol 1999 181 1026 35 10.1016/S0002-9378(99)70341-8 10521771 (Pubitemid 29503633)
28. Cigarette smoking and pre-eclampsia: their association and effects on clinical outcomes. MG Newman MK Lindsay W Graves, J Matern Fetal Med 2001 10 166 70 11444784
29. Super-obesity and risk for early and late pre-eclampsia. AK Mbah JL Kornosky S Kristensen EM August AP Alio PJ Marty V Belogolovkin K Bruder HM Salihu, BJOG 2010 117 997 1004 10.1111/j.1471-0528.2010.02593.x 20482533
30. Non-synonymous sequence variants within the oxygen-dependent degradation domain of the HIF1A gene are not associated with pre-eclampsia in the Finnish population. S Heino M Kaare S Andersson H Laivuori, BMC Med Genet 2008 9 96 101 10.1186/1471-2350-9-96 18980686
31. Single nucleotide polymorphism in the hypoxia-inducible factor-1alpha gene in colorectal carcinoma. T Kuwai Y Kitadai S Tanaka T Kuroda T Ochiumi S Matsumura N Oue W Yasui M Kaneyasu K Tanimoto M Nishiyama K Chayama, Oncol Rep 2004 12 1033 7 15492789
32. Common single nucleotide polymorphism of hypoxia-inducible factor-1alpha and its impact on the clinicopathological features of esophageal squamous cell carcinoma. TS Ling RH Shi GX Zhang H Zhu LZ Yu XF Ding, Chin J Dig Dis 2005 6 155 8 10.1111/j.1443-9573.2005.00223.x 16246222
33. Single nucleotide polymorphisms in the hypoxia-inducible factor-1alpha (HIF-1alpha) gene in human sporadic breast cancer. I Apaydin E Konac HI Onen M Akbaba E Tekin A Ekmekci, Arch Med Res 2008 39 338 45 10.1016/j.arcmed.2007.11. 012 18279708 (Pubitemid 351227407)
34. Allelic variations in angiogenic pathway genes are associated with preeclampsia. SK Srinivas AC Morrison CM Andrela MA Elovitz, Am J Obstet Gynecol 2010 202 445.e1 11 10.1016/j.ajog.2010.01.040
35. The effect of genetic diversity on angiogenesis. MS Rogers RJ D'Amato, Exp Cell Res 2006 312 561 74 10.1016/j.yexcr.2005.10.021 16321383 (Pubitemid 43290333)
36. Vascular endothelial growth factor gene polymorphisms and pre-eclampsia. D Papazoglou G Galazios MI Koukourakis I Panagopoulos EN Kontomanolis K Papatheodorou E Maltezos, Mol Hum Reprod 2004 10 321 4 10.1093/molehr/gah048 14997002 (Pubitemid 38714362)
37. Dinucleotide repeat polymorphism in Fms-like tyrosine kinase-1 (Flt-1) gene is not associated with preeclampsia. SY Kim JH Lim JH Yang MY Kim JY Han HK Ahn JS Choi SY Park MJ Kim HM Ryu, BMC Med Genet 2008 9 68 10.1186/1471-2350-9- 68 18631405